|FOOD AND DRUG
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
April 14, 1999Glaxo Wellcome Inc. Recalls Myleran Tablets
Myleran Tablets (busulfan), 2 mg, in 25 tablet bottles, indicated for the palliative
treatment of chronic myelogenous leukemia. Recall #D-167-9.
Glaxo Wellcome Inc., Zebulon, North Carolina.
Manufacturer, by letter on February 24, 1999.
8,426 units were shipped.